<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38577738</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1828-695X</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Multidisciplinary respiratory medicine</Title><ISOAbbreviation>Multidiscip Respir Med</ISOAbbreviation></Journal><ArticleTitle>Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">938</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5826/mrm.2024.938</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are uncertainties whether the impairment of lung diffusing capacity in COVID-19 is due to an alteration in the diffusive conductance of the alveolar membrane (Dm), or an alteration of the alveolar capillary volume (Vc), or a combination of both. The combined measurement DLNO and DLCO diffusion, owing to NO higher affinity and faster reaction rate with haemoglobin compared to CO, enables the simultaneous and rapid determination of both Vc and Dm. The aim of the present study was to better identify the precise cause of post-COVID-19 diffusion impairment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using the combined NO and CO gas transfer techniques (DLNO and DLCO), it is possible to better understand whether gas exchange abnormalities are due to membrane or alveolar capillary volume components. The present study was aimed at evaluating pulmonary gas exchange one year after severe COVID-19.&#xa0; Results: The cohort included 33 survivors to severe COVID-19 (median age 67 years, 70% male) with no pre-existing lung disease, who underwent clinical, lung function and imaging assessments at 12 months due to persistence of respiratory symptoms or radiological impairment. The gas exchange abnormalities were mainly determined by the compromise of the vascular component as demonstrated by vascular pattern of gas exchange impairment (i.e., DLNO/DLCO&#x2265;110%, 76% of the sample), and by a reduction of the Vc (73%), while the Dm was reduced only in 9% of the entire sample. We did not find a correlation between the gas exchange impairment and the extent of the chest CT alterations (DLCO p = 0.059 and DLNO p = 0.054), which on average were found to be mild (11% of the parenchyma).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In COVID-19 survivors who are still symptomatic or have minimal CT findings at one year, gas exchange abnormalities are determined by impairment of the vascular component, rather than the diffusive component of the alveolar membrane.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Imeri</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caroli</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di ricerche farmacologiche Mario Negri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrigoni</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di ricerche farmacologiche Mario Negri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonaffini</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy ; Post graduate school of Diagnostic Radiology University Milano Bicocca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sironi</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy ; Post graduate school of Diagnostic Radiology University Milano Bicocca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novelli</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raimondi</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiodini</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargiu</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Marco</LastName><ForeName>Fabiano</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII , Bergamo, BG, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Multidiscip Respir Med</MedlineTA><NlmUniqueID>101477642</NlmUniqueID><ISSNLinking>1828-695X</ISSNLinking></MedlineJournalInfo><CoiStatement><b>Conflict of interest:</b> The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38577738</ArticleId><ArticleId IdType="pmc">PMC10968839</ArticleId><ArticleId IdType="doi">10.5826/mrm.2024.938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Balbi M, Conti C, Imeri G, Caroli A, Surace A, Corsi A, et al. Post-discharge chest CT findings and pulmonary function tests in severe COVID-19 patients. Eur J Radiol Elsevier. 2021:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980523</ArticleId><ArticleId IdType="pubmed">33798931</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavorsky GS, Hsia CCW, Hughes JMB, Borland CDR, Gu&#xe9;nard H, Van Der Lee I, et al. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017;49(2):1600962.</Citation><ArticleIdList><ArticleId IdType="pubmed">28179436</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes JMB, Dinh-Xuan AT. The DL NO /DL CO ratio: Physiological significance and clinical implications. Respir Physiol Neurobiol. 2017;241:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28088638</ArticleId></ArticleIdList></Reference><Reference><Citation>Barisione G, Brusasco V. Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19. Physiol Rep. 2021:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903940</ArticleId><ArticleId IdType="pubmed">33625799</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200:e70&#x2013;e88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavorsky GS, Cao J. Reference equations for pulmonary diffusing capacity using segmented regression show similar predictive accuracy as GAMLSS models. BMJ Open Respir Res. 2022:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8852756</ArticleId><ArticleId IdType="pubmed">35172984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes JMB, van der Lee I. The TL,NO/TL,CO ratio in pulmonary function test interpretation. Eur Respir J. 2013;41:453&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">22936707</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20:1135&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia C, Doglioni C, Chilosi M, Piciucchi S, Dubini A, Rossi G, et al. Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J. 2022;60(4):2102411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932282</ArticleId><ArticleId IdType="pubmed">35301248</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez-Fern&#xe1;ndez M, Ramos-Hern&#xe1;ndez C, Garc&#xed;a-R&#xed;o F, P&#xe9;rez-Gonz&#xe1;lez A, Tilve-G&#xf3;mez A, Rodr&#xed;guez-Fern&#xe1;ndez P, et al. Evolution and long term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value. Respir Res BioMed Central Ltd. 2023;24:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9924196</ArticleId><ArticleId IdType="pubmed">36782191</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Negro RW, Turco P, Povero M. Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause. Multidiscip Respir Med. 2022;17:875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9577559</ArticleId><ArticleId IdType="pubmed">36268261</ArticleId></ArticleIdList></Reference><Reference><Citation>Seccombe LM, Heath D, Farah CS, Di Michiel JR, Veitch EM, Peters MJ. Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID-19 pneumonitis. Physiol Rep. 2023:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10076686</ArticleId><ArticleId IdType="pubmed">37020397</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, Schulze A, Evers G, Harmening K, Vink H, K&#xfc;mpers P, et al. Persistent capillary rarefication in long COVID syndrome. Angiogenesis Springer Science and Business Media B.V. 2023;26:53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>